However, patients who had resolved their impulse control disorders
at follow-up did not improve their depressive symptoms to the level that was seen in patients who never had ICDs, showing that "depressive symptoms at baseline did not predict the ICD outcome at follow-up," Dr.
Psychiatric comorbidities often include mood disorders (21% to 100%), eating disorders (8% to 85%), substance abuse disorders (24% to 46%) and other impulse control disorders
Impulse control disorders
in Parkinson's disease are often undiagnosed as patients tend to deny or minimize their existence, according to Dr.
Larger epidemiologic studies in these other populations are needed to examine the possible relationships between dopamine agonist treatment, other clinical features and impulse control disorders
," they concluded.
They focused on 1,580 reports of serious impulse control disorders
and excluded cases involved in litigation or clinical studies.
S rights for the use of opioid receptor antagonists in impulse control disorders
, including pathological gambling, and holds several other patents and intellectual property rights on nalmefene and its use in US, Europe, and Japan for the treatment of alcohol abuse.
Lori Rockmore, a psychologist with expertise in child development, impulse control disorders
, parent training and social and emotional learning.
Epidemiologic and clinical updates on impulse control disorders
With the tap of a finger, clinicians can access first line meds and dosing and better understand complex aspects of care like impulse control disorders
as they navigate their daily practice.
Increasing clinical and legal attention is being paid to impulse control disorders
(ICDs) including compulsive buying, pathological gambling, violence against women, and problematic Internet use, but information on some ICDs (e.
Additionally, the mental health organization plans to develop mobile applications for impulse control disorders
such as compulsive gambling, compulsive sexual disorders and possibly even eating disorders.
Specific topics include reform and the US Food and Drug Administration, suicide and antidepressants, genomics and new drug development, patenting and licensing concerns in psychiatric genetics, women's issues in clinical trials, the pharmacological treatment of mood disorders, research methodology in bipolar disorder clinical treatment trials, the utility of low-dose antidepressants, pharmacological trials for the treatment of substance use disorders, clinical psychopharmacology of patients with eating disorders, attention-deficit/hyperactivity disorder clinical trials, autism and Asperger's spectrum disorders, impulse control disorders
, potential benefits of herbal medicine for schizophrenia, adverse effects of antipsychotics, and alternative methodologies in clinical study design.